Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 101,322 | 68,742 | 60,804 | 52,523 | 52,084 |
| Operating Income | -99,214 | -68,742 | -60,804 | -52,523 | -52,084 |
| Interest Expense | 407 | 146 | 160 | 181 | 0 |
| Other Income | 3,650 | 4,341 | 3,643 | 3,781 | 2,883 |
| Pre-tax Income | -95,971 | -64,547 | -57,321 | -48,923 | -49,201 |
| Net Income Continuous | -95,975 | -64,547 | -57,321 | -48,923 | -49,201 |
| Net Income | $-95,975 | $-64,547 | $-57,321 | $-48,923 | $-49,201 |
| EPS Basic Total Ops | -1.62 | -1.07 | -1.01 | -0.87 | -0.93 |
| EPS Basic Continuous Ops | -1.62 | -1.07 | -1.01 | -0.87 | -0.93 |
| EPS Diluted Total Ops | -1.62 | -1.07 | -1.01 | -0.87 | -0.93 |
| EPS Diluted Continuous Ops | -1.62 | -1.07 | -1.01 | -0.87 | -0.93 |
| EBITDA(a) | $-98,349 | $-67,035 | $-59,238 | $-50,894 | $-50,421 |